MEGIN and BESA Expand Partnership for AI-Driven Brain Imaging Innovations

MEGIN and BESA Join Forces for AI-Driven Brain Imaging

On May 12, 2026, MEGIN, a leading provider of magnetoencephalography (MEG) technology, announced a significant expansion of its long-standing partnership with BESA GmbH, the top developer of brain signal analysis software. This renewed relationship aims to intertwine artificial intelligence (AI) and computational analysis within clinical and research MEG workflows, ensuring a seamless integration of the latest technological advancements.

This partnership marks an important evolution, focusing on the MEG Maps™ platform and its capabilities. For over ten years, MEGIN and BESA have been trailblazers in the clinical MEG sector, and this latest agreement represents a shift towards an open architecture model. The goal is to enable researchers and clinicians to access new analytical tools without compromising the workflow.

Gordon Baltzer, President of MEGIN, stated, "Our collaboration with BESA has been instrumental in shaping modern clinical MEG practices. By expanding our partnership, we are paving the way for the integration of AI and computational neuroscience into our core frameworks, setting a new standard in the MEG community."

The evolution of AI technologies necessitates a uniform platform that can adapt and evolve with ongoing changes in the field. The partnership will enhance the joint development of MEGreview™, a part of the MEG Maps platform, and provide MEGIN customers with access to BESA's comprehensive analytical tools. This is crucial as the demand for advanced analytical capabilities rises in the rapidly changing landscape of brain imaging.

Dr. Tobias Scherg, CEO of BESA GmbH, echoed these sentiments saying, "Our strategic alignment has matured significantly. Together, we have already redefined what is technologically possible in clinical and research MEG. The next chapter of this journey, driven by AI-enhanced analysis, must be built upon a cohesive and integrated platform, which we are committed to providing."

The partnership's focus on continuity is aimed at supporting existing customers, ensuring they remain at the forefront of MEG technology. Timothy P.L. Roberts, a prominent figure in pediatric radiology, shared his insights on the collaboration: "As a long-term BESA user, I recognize the immense value this partnership brings. It combines MEGIN's clinical expertise and BESA's analytical prowess, promising consistent and practical outcomes for clinical MEG."

The Future of MEG Imaging

As advancements in AI accelerate, MEGIN and BESA are prepared to unveil the details of their joint development pipeline over the coming months, including impending AI-enhanced analytical tools. They are also set to release updates about the MEG Maps platform, which promises to revolutionize the approach to brain imaging in both clinical and research settings.

For the global MEG community, this partnership signifies a transformative step towards a more integrated future. MEGIN, headquartered in Espoo, Finland, has over three decades of experience in MEG solutions, and with the inclusion of BESA’s extensive capabilities, they are set to enhance the clinical workflow and research methodologies profoundly.

In conclusion, the expanded collaboration between MEGIN and BESA is a promising development for the field of neuroscience. As new tools emerge, the commitment from both organizations to integrate these advancements within a reliable framework showcases their dedication to improving brain imaging techniques, thus benefiting clinicians and researchers alike.